Evaluation of tetanus antibody levels in adults in Yozgat, Turkey

Background/aim: To assess the immune status against tetanus in relation to self-declared vaccination status among an adult population in Yozgat, Turkey. Methods: Questionnaires and blood specimens were collected from 267 individuals over 18 years of age in Yozgat, Turkey. Antitetanus antibodies were determined quantitatively by enzyme-linked immunosorbent assay. Results: Among the 267 subjects (mean age 43.4 ± 15.6; male:female, 133:134) 168 (62.9%) had protective level of tetanus antibody titers. There was a characteristic distribution of the tetanus antibody titers in different age groups as it dropped with increasing age. Protective immunity was obtained in 74.1% of urban and 47.9% of rural participants. The lowest immunity was observed among farmers (53.3%) and housewives (55.6%) when compared to other occupations. Protective antibody titers were detected in 25% of the individuals who had not finished any school, while the rate was 83.7% in those who had graduated from university. While the protection rate in women who had been vaccinated during pregnancy was 78.3%, this rate was 39.2% in nonvaccinated women. Conclusion: Our findings confirm that only 62.9% of the population is immunized against tetanus, with a lack of coverage in particular for the elderly and in rural areas. It is necessary to follow the recommendations for 10-year boosters for tetanus.

PDF

___

1. Reddy P, Bleck TP. Clostridium tetani (Tetanus). In: Mandel GL, Bennetts JE, Dolin R editors. Principles and Practice of Infectious Diseases, 7th ed. Philadelphia, PA, USA: Churchill Livingstone; 2010. pp. 30913096.
2. Drew LW, Ryan JK. Clostridium, peptostreptococcus, bacteriaodes, and other anaerobes. In: Ryan JK, Ray GC, editors. Sherris Medical Microbiology. 5th ed. New York, NY, USA: McGraw-Hill Companies; 2010. pp. 526.
3. Coplu N, Esen B, Gozalan A, Miyamura K, Yoshida I, Kurtoglu D, Dogan ON, Afacan G, Unal A, Ishida S et al. Tetanus antibody assay combining. In-house ELISA and particle agglutination test and its serosurvey application in a province in Turkey. Jpn J Infect Dis. 2004; 57: 97102.
4. Kurtoglu D, Gozalan A, Coplu N, Miyamura K, Morita M, Esen B, Akın L. Community- based seroepidemiology of tetanus in three selected provinces in Turkey. Jpn J Infect Dis 2004; 57: 1016.
5. Tosun YS, Atman Ü, Kasırga E, İnceboz Ü. Is the booster vaccine for tetanus in older age necessary? Turk Mikrobiyol Cem Derg 2003; 33: 148152 (article in Turkish with an abstract in English).
6. Mercan OK, Tunger Ö, Akçalı S, Dinç G, Vural Ş, Çetin ÇB. Manisa bölgesinde erişkin yaş grubunda tetanoz antikor düzeylerinin araştırılması. ANKEM Derg 2008; 22: 67 (in Turkish).
7. Ergonul O, Sozen T, Tekeli E. The immunity to tetanus among adults in Turkey. Scand J Infect Dis 2001; 33: 728730.
8. Filia A, Bella A, von Hunolstein C, Pinto A, Alfarone G, Declich S, Rota MC. Tetanus in Italy 2001-2010: A continuing threat in older adults. Vaccine 2014; 32: 639644.
9. Yuan L, Lau W, Thipphawong J, Kasenda M, Xie F, Bevilacqua J. Diphtheria and tetanus immunity among blood donors in Toronto. CMAJ 1997; 156: 985990.
10. Stark K, Schonfeld C, Barg J, Molz B, Vornwald A, Bienzle U. Seroprevalence and determinants of diphtheria, tetanus and poliomyelitis antibodies among adults in Berlin, Germany. Vaccine 1999; 17: 844850.
11. Ichhpujani RL, Grover SS, Joshi PR, Kumari S, Verghese T. Prevalence of diphtheria and tetanus antibodies in young adults in Delhi. J Commun Dis 1993; 25: 2729.
12. Vernacchio L, Madico G, Verastegui M, Diaz F, Collins TS, Gilman RH. Neonatal tetanus in Peru: risk assessment with modified enzyme-linked immunosorbent assay and toxoid skin test. Am J Public Health 1993; 83: 17541756.
13. Kurtzhals JA, Kjeldsen K, Hey AS, Okongo-Odera EA, Heron I. Immunity to tetanus and diphtheria in rural Africa. Am J Trop Med Hyg 1997; 56: 576579.
14. Tosun S, Deveci S, Yücetürk M, Dönmez AB, Kaplan Y. Investigation of tetanus antitoxin titer levels in people over forty years of age. Turkiye Klinikleri J Med Sci 2012; 32: 301 307.
15. Weiss BP, Strassburg MA, Feeley JC. Tetanus and diphtheria immunity in an elderly population in Los Angeles County. Am J Pub Health 1983; 73: 802804.
16. Viljanen MK, Nieminen S. Immunity to tetanus in Finland. Scand J Infect Dis 1980; 12: 211213.
17. Lau RCH. Diphteria, tetanus, pertussis: antibody detection in New Zealand. New Zealand Med J 1987; 100: 481483.
18. Matzkin H, Regev S, Kedem R, Nili E. A study of the factors influencing tetanus immunity in Israeli male adults. J Infection 1985; 11: 7178.
19. Symeonidis N, Symeonidis C, Souliou E. Serological survey of immunity to tetanus in adult population of Northern Halkidiki, Greece. Eur J Epidemiol 2003; 18: 11471152.
20. Ozcirpici B, Aydın N, Coskun F, Tuzun H, Ozgur S. Vaccination coverage of children aged 12-23 months in Gaziantep, Turkey: comparatives results of two studies carried out by lot quality technique: what changed after family medicine? BMC Public Health 2014; 3: 217.
21. Ozturk A, Gokahmetoglu S, Erdem F, Misguroglu AS. Tetanus antitoxin levels among adults over 40 years of age in Central Anatolia, Turkey. Clin Microbiol Infect 2003; 9: 3338.
22. Kiliç D, Kaygusuz S, Saygun M, Çakmak A, Üzer H, Doğancı L. Seroprevalence of tetanus immunity among noninsulindependent diabetes mellitus patients. J Diabetes Complications 2003; 17: 258263.